Dear customers, dear friends,

The second year under pandemic conditions draws to its end.

We all had high hopes when the vaccination campaign started in early 2021. Unfortunately the virus has still more arrows in its quiver than anybody expected - and we may have to face the fact that the Greek alphabet will not be enough to name all the mutants that are likely to come in the future!

Thanks to the great progress, we have made in developing adapted vaccines and the fact that vaccination against the wild-type also provides quite good protection against all known corona virus mutants, we will finally celebrate our victory over it - perhaps later than expected - but for sure!

2021 was a very special year for DiaSys: We celebrated our 30th company anniversary! What a pity that we could not do it with all our friends around the world! But the time will come when we all will meet again!
To celebrate our anniversary with you anyway, we have come up with some nice sales campaigns that will help your business and, in the best case, generate some success stories! We look forward to hearing them!

You may remember the introduction of our own Procalcitonin assay last year. We had great success with this, especially in Germany. We are confident that this will be possible in your countries as well!

Of course, our developments are still ongoing: A major milestone of our R&D team this year was the development of our SARS-CoV-2 UTAB FS test for the detection of total antibodies against the SARS-CoV-2 virus. This test has recently become available in WHO standardized units. We hope this test will find its way to many of your customers!

Another highlight was the launch of our new homogeneous tests HDL-c direct FS and LDL-c direct FS for the determination of HDL and LDL cholesterol. The respons®940 has also gained a lot of momentum - by itself and even more by the 30th anniversary campaign!

In the last few months, we all worked hard to pass our triple audit, which we had at the same time as our exhibition presence at MEDICA: DIN EN 13485:2016, MDSAP and IVDR audit - all at once! We are pleased that we passed them all so well. However, there is still a lot of work to do to complete all the documents required for the IVDR now and in the future - so the year 2022 will still be very busy with all that activities!

But now that this year is about to end, we would like to wish you all, your families and friends a peaceful and quiet time. Hopefully you can relax a bit and get new power for the coming year.

We would like to close with a modified motto of DiaSys:
Choosing Quality - Choosing Vaccination!

All the best, Merry Christmas and a happy and successful New Year 2022!
The staff and management board of DiaSys Diagnostic Systems GmbH

shareshareshare